These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The clinical applications of curcumin: current state and the future. Fan X; Zhang C; Liu DB; Yan J; Liang HP Curr Pharm Des; 2013; 19(11):2011-31. PubMed ID: 23116310 [TBL] [Abstract][Full Text] [Related]
23. Curcumin marinosomes as promising nano-drug delivery system for lung cancer. Ibrahim S; Tagami T; Kishi T; Ozeki T Int J Pharm; 2018 Apr; 540(1-2):40-49. PubMed ID: 29408473 [TBL] [Abstract][Full Text] [Related]
24. Advances in clinical study of curcumin. Yang C; Su X; Liu A; Zhang L; Yu A; Xi Y; Zhai G Curr Pharm Des; 2013; 19(11):1966-73. PubMed ID: 23116307 [TBL] [Abstract][Full Text] [Related]
25. Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. Ahsan H; Parveen N; Khan NU; Hadi SM Chem Biol Interact; 1999 Jul; 121(2):161-75. PubMed ID: 10418962 [TBL] [Abstract][Full Text] [Related]
26. Chemical and structural features influencing the biological activity of curcumin. Priyadarsini KI Curr Pharm Des; 2013; 19(11):2093-100. PubMed ID: 23116315 [TBL] [Abstract][Full Text] [Related]
27. Curcumin AntiCancer Studies in Pancreatic Cancer. Bimonte S; Barbieri A; Leongito M; Piccirillo M; Giudice A; Pivonello C; de Angelis C; Granata V; Palaia R; Izzo F Nutrients; 2016 Jul; 8(7):. PubMed ID: 27438851 [TBL] [Abstract][Full Text] [Related]
28. Novel anti-prostate cancer curcumin analogues that enhance androgen receptor degradation activity. Shi Q; Shih CC; Lee KH Anticancer Agents Med Chem; 2009 Oct; 9(8):904-12. PubMed ID: 19663790 [TBL] [Abstract][Full Text] [Related]
29. Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers. Mbese Z; Khwaza V; Aderibigbe BA Molecules; 2019 Nov; 24(23):. PubMed ID: 31801262 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of glucosyl curcuminoids. Bhaskar Rao A; Prasad E; Deepthi SS; Ansari IA Arch Pharm (Weinheim); 2014 Nov; 347(11):834-9. PubMed ID: 25142301 [TBL] [Abstract][Full Text] [Related]
31. New Promising Therapeutic Avenues of Curcumin in Brain Diseases. Benameur T; Giacomucci G; Panaro MA; Ruggiero M; Trotta T; Monda V; Pizzolorusso I; Lofrumento DD; Porro C; Messina G Molecules; 2021 Dec; 27(1):. PubMed ID: 35011468 [TBL] [Abstract][Full Text] [Related]
32. Curcumin as a potential protective compound against cardiac diseases. Jiang S; Han J; Li T; Xin Z; Ma Z; Di W; Hu W; Gong B; Di S; Wang D; Yang Y Pharmacol Res; 2017 May; 119():373-383. PubMed ID: 28274852 [TBL] [Abstract][Full Text] [Related]
33. TPA-induced up-regulation of activator protein-1 can be inhibited or enhanced by analogs of the natural product curcumin. Weber WM; Hunsaker LA; Gonzales AM; Heynekamp JJ; Orlando RA; Deck LM; Vander Jagt DL Biochem Pharmacol; 2006 Oct; 72(8):928-40. PubMed ID: 16934760 [TBL] [Abstract][Full Text] [Related]
34. An overview of structure-activity relationship studies of curcumin analogs as antioxidant and anti-inflammatory agents. Arshad L; Haque MA; Abbas Bukhari SN; Jantan I Future Med Chem; 2017 Apr; 9(6):605-626. PubMed ID: 28394628 [TBL] [Abstract][Full Text] [Related]
35. Current evidence and future perspectives for curcumin and its analogues as promising adjuncts to oxaliplatin: state-of-the-art. Zangui M; Atkin SL; Majeed M; Sahebkar A Pharmacol Res; 2019 Mar; 141():343-356. PubMed ID: 30641277 [TBL] [Abstract][Full Text] [Related]
36. Comparative anti-inflammatory activities of curcumin and tetrahydrocurcumin based on the phenolic O-H bond dissociation enthalpy, ionization potential and quantum chemical descriptor. Murakami Y; Ishii H; Takada N; Tanaka S; Machino M; Ito S; Fujisawa S Anticancer Res; 2008; 28(2A):699-707. PubMed ID: 18507010 [TBL] [Abstract][Full Text] [Related]
37. Mechanistic insight into carnosol-mediated pharmacological effects: Recent trends and advancements. Kashyap D; Kumar G; Sharma A; Sak K; Tuli HS; Mukherjee TK Life Sci; 2017 Jan; 169():27-36. PubMed ID: 27871947 [TBL] [Abstract][Full Text] [Related]
38. Delivery of curcumin and medicinal effects of the copper(II)-curcumin complexes. Leung MH; Harada T; Kee TW Curr Pharm Des; 2013; 19(11):2070-83. PubMed ID: 23116313 [TBL] [Abstract][Full Text] [Related]
39. Anti-oxidant activities of curcumin and related enones. Weber WM; Hunsaker LA; Abcouwer SF; Deck LM; Vander Jagt DL Bioorg Med Chem; 2005 Jun; 13(11):3811-20. PubMed ID: 15863007 [TBL] [Abstract][Full Text] [Related]
40. Mitotic spindle defects and DNA damage induced by dimethoxycurcumin lead to an intrinsic apoptosis pathway in HepG2/C3A cells. Zanetti TA; Biazi BI; Coatti GC; Baranoski A; Marques LA; Corveloni AC; Mantovani MS Toxicol In Vitro; 2019 Dec; 61():104643. PubMed ID: 31513842 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]